On Monday, Oscar Health earned an upgrade to its Relative Strength (RS) Rating, from 89 to 93.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
History reveals that the top-performing stocks tend to have an 80 or better RS Rating in the early stages of their moves.
Oscar Health is not currently near a potential buy zone. See if the stock goes on to build a sound pattern that could launch a new move.
Earnings growth moved up last quarter from 0% to 48%, but sales fell from 67% to 42%.
The company earns the No. 1 rank among its peers in the Insurance-Accident & Healthcare industry group. Trupanion and Unum Group are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
